Targeted Oncology1d
Ide-cel in Multiple Myeloma Post-Transplant: Insights From Garfall
Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.
Stocks to watch: Biocon, Coforge, Adani Wilmar, Ola Electric, Power Grid among shares to remain in focus today
The company announced that it has secured three orders valued at around ₹500 crore from Power Grid Corporation of India Ltd ...
PLI boost: Cancer patients can hope for affordable drugs in India
New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...
Here's why Biocon share price popped 3% in trade on March 5; details here
The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received ...
Biocon shares up 3% after US FDA nod for key cancer drugs
Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, ...
Stocks To Watch: Adani Wilmar, Ola Electric, Ambuja Cements, ONGC, RVNL, And Others
Shares of firms like Adani Wilmar, Ola Electric, Ambuja Cements, ONGC, RVNL, and others will be in focus on Wednesday's trade ...
Stocks to Watch, March 5: Adani Wilmar, Coforge, Biocon, Ola Electric, RVNL
The company's subsidiary, Biocon Pharma, has received USFDA approvals for Lenalidomide capsules and Dasatinib tablets, and ...
Stocks to Watch Today: Biocon, Coforge, GE Vernova, Power Grid, JSW Energy, Welspun Specialty, Rail Vikas Nigam in focus on 5 March
Stocks like Ola Electric Mobility, Grasim Industries, RHI Magnesita India, Apollo Hospitals Enterprise, Walchandnagar ...
Medical Dialogues7d
Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma
Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in ...